Related content

Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?

By Hofman Véronique   Lassalle Sandra   Bence Coraline   Long-Mira Elodie   Nahon-Estève Sacha   Heeke Simon   Lespinet-Fabre Virginie   Butori Catherine   Ilié Marius   Hofman Paul  

Cancers, Vol. 10, Iss. 3, 2018-03 ,pp. : 70-70

MDPI

Access to resources Recommend Favorite

Significance of Matrix Metalloproteinase 9 Expression as Supporting Marker to Cytokeratin 19 mRNA in Sentinel Lymph Nodes in Breast Cancer Patients

By Murawski Marek   Woźniak Marta   Duś-Szachniewicz Kamila   Kołodziej Paweł   Rzeszutko Marta   Ziółkowski Piotr  

International Journal of Molecular Sciences, Vol. 17, Iss. 4, 2016-04 ,pp. : 571-571

MDPI

Access to resources Recommend Favorite

Influence of Preoperative Serum Aspartate Aminotransferase (AST) Level on the Prognosis of Patients with Non-Small Cell Lung Cancer

By Chen Shu-Lin   Xue Ning   Wu Mian-Tao   Chen Hao   He Xia   Li Jian-Pei   Liu Wan-Li   Dai Shu-Qin  

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-09 ,pp. : 1474-1474

MDPI

Access to resources Recommend Favorite

Elevated Serum Concentration of Chitinase 3-Like 1 is an Independent Prognostic Biomarker for Poor Survival in Lung Cancer Patients

By  

Cellular Physiology and Biochemistry, Vol. 38, Iss. 2, 2016-0 ,pp. : 461-468

Karger

Access to resources Recommend Favorite

Circulating Long Non-Coding RNAs Act as Biomarkers for Predicting ¹³¹I Uptake and Mortality in Papillary Thyroid Cancer Patients with Lung Metastases

By  

Cellular Physiology and Biochemistry, Vol. 40, Iss. 6, 2016-12 ,pp. : 1377-1390

Karger

Access to resources Recommend Favorite